# H&Q Asia Pacific

> H&Q Asia Pacific is a VC fund backing Information Technology and Software. See 40 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Palo Alto, United States
- Total investments: 40
- Last investment: Sep 2021
- Lead investor: 38%
- Last updated: Aug 2026
- Website: http://www.hqap.com

H&Q Asia Pacific (H&QAP) is a leading Asian private equity firm. Originally founded by Dr. Ta-lin Hsu as a division of U.S. investment banking firm Hambrecht & Quist, H&QAP is currently an independent organization that conducts both later-stage control investments and earlier-stage venture capital investments. It focuses on growthsectors including technology, technology manufacturing, consumer brands and financial services. The firm's offices are located in the principal markets of Asia as well as in the Silicon Valley, providing it with a unique combination of local market presence and global perspective. H&QAP is dedicated to identifying superior commercial potential in Asia and working closely with companies to unlock that untapped potential. Throughout its rich history, H&QAP has developed an extensive network specifically geared towards helping its portfolio companies emerge into global business leaders.

## Contacts

5 contacts available for H&Q Asia Pacific. Shizune tracks 8 team members at H&Q Asia Pacific. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/h-a-asia-pacific?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $5.3M–$31M |
| Series B | $7.2M–$32M |
| Series C | $7.9M–$630M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Information Technology | 9 | 23% |
| Software | 8 | 20% |
| Manufacturing | 6 | 15% |
| Biotechnology | 5 | 13% |
| Hardware | 4 | 10% |

74 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 12 | 30% |
| Series B | 9 | 23% |
| Series C | 8 | 20% |
| Funding Round | 6 | 15% |
| Series F | 2 | 5% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 22 | 55% |
| China | 4 | 10% |
| Taiwan | 2 | 5% |
| Singapore | 2 | 5% |
| India | 1 | 3% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Benson He | Managing Director | 0 | https://shizune.co/investors/profile/benson-he |
| Jong Won Lee | Managing Director | 0 | https://shizune.co/investors/profile/jong-won-lee |
| Jung Jin Lee | Managing Director | 0 | https://shizune.co/investors/profile/jung-jin-lee |
| Mark Hsu | Managing Director | 0 | https://shizune.co/investors/profile/mark-hsu-2 |
| Robert Shen | Managing Director | 1 | https://shizune.co/investors/profile/robert-shen |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Paperspace | Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Company’s large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomasssorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda. |  | Series F | Sep 27, 2021 |  |
| Ceres | Ceres applies genetic research and trait development to improve crop productivity, enhance quality characteristics, and support cultivation under varied environmental conditions. Its technology portfolio includes DNA-based trait solutions designed for integration across multiple crop types and end markets. Ceres also provides bioinformaticscapabilities through its Persephone software, which enables structured exploration and analysis of genomic data. |  | Series F | Sep 27, 2021 |  |
| FST NETWORK | FST Network's Virtual Assistive Data Officer provides a low-code platform to help Data Users to create new logics for each data processes with labelling functionalities. FST Network's Virtual Assistive Data Officer also comes with a search engine functionality to help Enterprises to find correlation of their data, getting full overview& lineage of Enterprises's data & system. | $2.9M | Seed | May 15, 2021 |  |
| Formosa Pharmaceuticals | Formosa Pharmaceuticals is a biopharmaceutical firm that specializes in ophthalmology and oncology. | $21.2M | Series C | Apr 16, 2021 |  |
| EOC Pharma Group | EOC Pharma is an integrated biopharmaceutical company that is focused on the manufacturing, development and commercialization of innovative global oncology products in China. They have adopted a licensing model in order to build EOC’s innovative pipeline by plugging their partner’s molecule into EOC’s “core engine” of local manufacturing,clinical development, regulatory filing, and commercialization. The company has a pipeline of seven novel products from global biopharmaceutical partners that are potentially first- and best-in-class. Until now, EOC has obtained four Class I innovative drug CTA approvals and initiated clinical studies of four lead products in China.,EOC has a team of entrepreneurs and consultants with overseas background that boasts of first-class pharmaceutical R&D expertise as well as rich industry experience. The company owns an 8,000 square meter cGMP manufacturing facility in Taizhou, China Medical City and has offices in Shanghai, Beijing, Hong Kong and Los Angeles.EOC will leverage forward-looking licensing which will provide product opportunities to their integrated platform, generating a highly strategic portfolio. Ultimately, this will position EOC at the top of oncology innovation in China. | $32M | Series B | Nov 07, 2017 |  |
| Hyphen Group | Hyphen Group is a network of finance companies. They empower and connect people to a better financial future through innovative tools, personalized digital experiences, and expert insights, and accelerate the digitization of the financial industry. | $50M | Series B | Jun 01, 2017 |  |
| One | One Inc provides insurance companies a digital payments platform designed to increase retention, decrease admin expenses, and mitigate data security risk – while simplifying compliance. The One Inc Digital Payments Platform combines multi-channel digital communications with electronic payment processing and disbursement, creating a frictionlesspremiums and claims payments experience. As one of the fastest growing digital payments platforms in the insurance industry, One Inc manages billions of dollars per year in premiums and claims payments. For more information, please visit www.oneincsystems.com. | $20M | Series B | Dec 14, 2016 |  |
| Viscovery | Viscovery is a leading Vision Artificial Intelligence company based on Deep Learning and Computer Vision technology. Our revolutionary visual discovery service provides image and video recognition solutions for enterprises. Established in 2013, Viscovery has collaborated with Intel, NVIDIA, AWS, and received international recognition and investmentfrom Intel, Alibaba, Quanta, CDIB, H&Q, etc.Viscovery is dedicated to providing comprehensive recognition solutions for Smart Retail, Smart E-Commerce, Smart Media, Augmented Reality, Smart Factory and more. With our R&D team based in Taipei and consisting of computer scientists and engineers with expertise in Artificial Intelligence, Computer Vision, Machine Learning and Deep Learning, Viscovery has been exploring the unlimited possibilities via Vision AI, and providing customized recognition solutions for enterprises. (www.viscovery.com) | $10M |  | Oct 18, 2016 |  |
| Efficient Drivetrains | Efficient Drivetrains Inc. (EDI) designs and manufactures high-efficiency continuously variable transmissions (CVT) for electric vehicle developers, manufacturers, and suppliers. EDI's hybrid electric drivetrain systems and technologies provide significant cost and efficiency advantages by using parallel drivetrain architectures, uniquecomponents, proprietary control software and algorithms. The company's products have direct applications in Electric Vehicles (EVs), Hybrid Electric Vehicles (HEVs), and Plugin Hybrid Electric Vehicles (PHEVs), across nearly all platforms classes and configurations including trucks, buses and cars. | $7.9M | Series C | Jun 20, 2016 |  |
| Huizuche | Huizuche is the operator of a car rental service platform designed to offer users a convenient car rental experience overseas. | $28.3M | Series B | Jun 14, 2016 |  |

10 of 40 investments shown.

## Co-investors
- [Harbinger Ventures](https://shizune.co/investors/profile/harbinger-ventures) — VC Fund, 3 deals together
- [U.S. Venture Partners](https://shizune.co/investors/profile/us-venture-partners) — VC Fund, 3 deals together
- [Western Technology Investment](https://shizune.co/investors/profile/western-technology-investment) — VC Fund, 3 deals together
- [Acorn Campus Ventures](https://shizune.co/investors/profile/acorn-campus-ventures) — VC Fund, 2 deals together
- [China Development Industrial Bank (CDIB)](https://shizune.co/investors/profile/china-development-industrial-bank-cdib) — VC Fund, 2 deals together
- [CMF Venture Capital](https://shizune.co/investors/profile/cmf-venture-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [National Development Fund of Taiwan Government](https://shizune.co/investors/profile/national-development-fund-of-taiwan-government) — VC Fund
- [Darwin Venture Management](https://shizune.co/investors/profile/darwin-venture-management) — VC Fund
- [AVA Angels](https://shizune.co/investors/profile/ava-angels) — VC Fund

## Featured in investor lists
- [Wellness Investors in China](https://shizune.co/investors/wellness-investors-china)
- [Wellness VC Funds in China](https://shizune.co/investors/wellness-vc-funds-china)
- [Marketplace Investors in Taiwan](https://shizune.co/investors/marketplace-investors-taiwan)
- [Marketplace VC Funds in Taiwan](https://shizune.co/investors/marketplace-vc-funds-taiwan)
- [Artificial intelligence VC Funds in Taiwan](https://shizune.co/investors/artificial-intelligence-vc-funds-taiwan)
- [Hardware Investors in Taiwan](https://shizune.co/investors/hardware-investors-taiwan)

## FAQ

### What does H&Q Asia Pacific invest in?

H&Q Asia Pacific invests primarily in Information Technology, Software and Manufacturing startups, most often at Series A and Series B stage. Most of the 40 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is H&Q Asia Pacific's check size?

H&Q Asia Pacific typically joins rounds of $5.3M–$31M at Series A, $7.2M–$32M at Series B and $7.9M–$630M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds H&Q Asia Pacific participates in.

### How do I contact H&Q Asia Pacific?

Public channels for H&Q Asia Pacific include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at H&Q Asia Pacific?

The team at H&Q Asia Pacific includes Benson He (Managing Director), Jong Won Lee (Managing Director) and Jung Jin Lee (Managing Director), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co